281 related articles for article (PubMed ID: 29545604)
1. Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.
Miskolczi Z; Smith MP; Rowling EJ; Ferguson J; Barriuso J; Wellbrock C
Oncogene; 2018 Jun; 37(23):3166-3182. PubMed ID: 29545604
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Localization of Yes-Associated Protein Is Associated With Tumor Progression in Cutaneous Melanoma.
Ryu HJ; Kim C; Jang H; Kim SI; Shin SJ; Chung KY; Torres-Cabala C; Kim SK
Lab Invest; 2024 May; 104(5):102048. PubMed ID: 38490470
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
[TBL] [Abstract][Full Text] [Related]
4. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
[TBL] [Abstract][Full Text] [Related]
5. Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity.
Vivas-García Y; Falletta P; Liebing J; Louphrasitthiphol P; Feng Y; Chauhan J; Scott DA; Glodde N; Chocarro-Calvo A; Bonham S; Osterman AL; Fischer R; Ronai Z; García-Jiménez C; Hölzel M; Goding CR
Mol Cell; 2020 Jan; 77(1):120-137.e9. PubMed ID: 31733993
[TBL] [Abstract][Full Text] [Related]
6. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.
Vlčková K; Vachtenheim J; Réda J; Horák P; Ondrušová L
J Cell Mol Med; 2018 Apr; 22(4):2240-2251. PubMed ID: 29369499
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling identifies microphthalmia-associated transcription factor (MITF) and Dickkopf-1 (DKK1) as regulators of microenvironment-driven alterations in melanoma phenotype.
Hartman ML; Talar B; Noman MZ; Gajos-Michniewicz A; Chouaib S; Czyz M
PLoS One; 2014; 9(4):e95157. PubMed ID: 24733089
[TBL] [Abstract][Full Text] [Related]
8. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.
Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J
Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682
[TBL] [Abstract][Full Text] [Related]
9. Hierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-catenin signaling in melanoma phenotype switching.
Lüönd F; Pirkl M; Hisano M; Prestigiacomo V; Kalathur RK; Beerenwinkel N; Christofori G
Life Sci Alliance; 2022 Feb; 5(2):. PubMed ID: 34819356
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
[TBL] [Abstract][Full Text] [Related]
11. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.
Nallet-Staub F; Marsaud V; Li L; Gilbert C; Dodier S; Bataille V; Sudol M; Herlyn M; Mauviel A
J Invest Dermatol; 2014 Jan; 134(1):123-132. PubMed ID: 23897276
[TBL] [Abstract][Full Text] [Related]
12. Mutual dependence of the MRTF-SRF and YAP-TEAD pathways in cancer-associated fibroblasts is indirect and mediated by cytoskeletal dynamics.
Foster CT; Gualdrini F; Treisman R
Genes Dev; 2017 Dec; 31(23-24):2361-2375. PubMed ID: 29317486
[TBL] [Abstract][Full Text] [Related]
13. Somatic Hypermutation of the
Zhang X; Tang JZ; Vergara IA; Zhang Y; Szeto P; Yang L; Mintoff C; Colebatch A; McIntosh L; Mitchell KA; Shaw E; Rizos H; Long GV; Hayward N; McArthur GA; Papenfuss AT; Harvey KF; Shackleton M
Mol Cancer Res; 2019 Jul; 17(7):1435-1449. PubMed ID: 30833299
[TBL] [Abstract][Full Text] [Related]
14. Aging of the skeletal muscle extracellular matrix drives a stem cell fibrogenic conversion.
Stearns-Reider KM; D'Amore A; Beezhold K; Rothrauff B; Cavalli L; Wagner WR; Vorp DA; Tsamis A; Shinde S; Zhang C; Barchowsky A; Rando TA; Tuan RS; Ambrosio F
Aging Cell; 2017 Jun; 16(3):518-528. PubMed ID: 28371268
[TBL] [Abstract][Full Text] [Related]
15. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
[TBL] [Abstract][Full Text] [Related]
16. BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene.
Saladi SV; Wong PG; Trivedi AR; Marathe HG; Keenen B; Aras S; Liew ZQ; Setaluri V; de la Serna IL
Pigment Cell Melanoma Res; 2013 May; 26(3):377-91. PubMed ID: 23480510
[TBL] [Abstract][Full Text] [Related]
17. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
[TBL] [Abstract][Full Text] [Related]
18. The HU177 Collagen Epitope Controls Melanoma Cell Migration and Experimental Metastasis by a CDK5/YAP-Dependent Mechanism.
Caron JM; Han X; Contois L; Vary CPH; Brooks PC
Am J Pathol; 2018 Oct; 188(10):2356-2368. PubMed ID: 30118657
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma.
Miller AJ; Du J; Rowan S; Hershey CL; Widlund HR; Fisher DE
Cancer Res; 2004 Jan; 64(2):509-16. PubMed ID: 14744763
[TBL] [Abstract][Full Text] [Related]
20. TIAM1 Antagonizes TAZ/YAP Both in the Destruction Complex in the Cytoplasm and in the Nucleus to Inhibit Invasion of Intestinal Epithelial Cells.
Diamantopoulou Z; White G; Fadlullah MZH; Dreger M; Pickering K; Maltas J; Ashton G; MacLeod R; Baillie GS; Kouskoff V; Lacaud G; Murray GI; Sansom OJ; Hurlstone AFL; Malliri A
Cancer Cell; 2017 May; 31(5):621-634.e6. PubMed ID: 28416184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]